NorthCoast has made a co-investment in Comprehensive EyeCare Partners to support its recapitalization, enhancing its position in the ophthalmology management market.
Information on the Target
Comprehensive EyeCare Partners, commonly referred to as CompEye, is a prominent ophthalmology practice management firm located near Las Vegas, Nevada. The company specializes in the management and operation of ophthalmology clinics, providing essential services in eye care to patients throughout the Western United States. CompEye has established itself as a leader in the sector, leveraging advanced technology and a commitment to quality care to enhance patient outcomes.
With a strong network of ophthalmologists and associated healthcare providers, CompEye focuses on streamlining practice operations, optimizing patient management, and ensuring high standards of clinical excellence. This recapitalization, through subordinated debt and preferred equity, aims to bolster CompEye's growth trajectory and expand its operational capacities.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The ophthalmology practice management industry in the United States has seen substantial growth in recent years, driven by an increasing prevalence of eye-related disorders and advancements in eye car
Similar Deals
Thesis Capital Partners → The Ridge Ohio
2025
Everberg Capital → Allied OMS
2025
Aldrich Capital Partners → Persivia
2025
Wellspring Capital Management → Summit Spine & Joint Centers
2025
Perceptive Advisors, LLC → TELA Bio, Inc.
2025
NorthCoast
invested in
Comprehensive EyeCare Partners
in 2025
in a Recapitalization deal